Last reviewed: June 7, 2026

Last updated: June 7, 2026

Written by: Jay Hastings, CEO of PlexusDx

Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance.

Medically reviewed by: Jayden Lee, PharmD, EMBA

Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.

This article is part of the PlexusDx Education Hub — science-backed guidance on GLP-1 medications, metabolic health, and precision weight management.

Semaglutide is a glucagon-like peptide-1 (GLP-1) receptor agonist originally developed for type 2 diabetes that has demonstrated significant weight loss results in clinical trials. Research shows adults using semaglutide lost an average of 15% of their body weight over 68 weeks. PlexusDx provides access to compounded semaglutide injections through licensed 503A pharmacies, making personalized weight loss therapy available without insurance requirements.

How Semaglutide Works for Weight Loss

Semaglutide activates GLP-1 receptors in your brain that control hunger signals and food intake. When you take semaglutide, these receptors send messages that make you feel fuller with smaller meals and reduce cravings between meals. This mechanism is why appetite suppression happens naturally without requiring extreme willpower or restrictive dieting.

Your stomach also empties more slowly on semaglutide, which extends feelings of fullness after eating. Combined with reduced hunger hormone production, this dual action creates sustainable weight loss without the constant battle against appetite that traditional diets require. The medication works with your body's natural signaling systems rather than forcing calorie restriction through stimulants.

Who Should Consider Semaglutide Injection

Adults with a body mass index (BMI) of 27 or higher who struggle with appetite control may benefit from semaglutide therapy. You don't need a diabetes diagnosis to qualify—weight management is a valid clinical indication. PlexusDx serves patients across all 50 states regardless of insurance status or prior authorization requirements.

Semaglutide is most effective for people whose weight challenges relate to hunger, portion control, or constant food thoughts rather than purely behavioral eating patterns. Your individual response depends on genetic factors affecting GLP-1 receptor sensitivity, which PlexusDx can identify through the Precision Peptide Genetic Test. This assessment examines variants in the GLP1R gene and related metabolic pathways to predict your personalized treatment response.

Medical Conditions That May Require Caution

Certain medical histories warrant careful evaluation before starting semaglutide. A personal or family history of medullary thyroid cancer or multiple endocrine neoplasia syndrome type 2 represents an absolute contraindication. Additionally, severe kidney disease, active pancreatitis, or poorly controlled blood pressure may require medical monitoring or alternative approaches.

Patients taking other diabetes medications might need dose adjustments when adding semaglutide due to interaction effects on blood sugar. Those with a history of severe gastrointestinal disease should discuss potential risks with their healthcare provider before beginning treatment. PlexusDx recommends a consultation with your primary care physician to review your complete medical history before starting therapy.

Starting Semaglutide at PlexusDx

PlexusDx offers compounded semaglutide injection starting at $149 per month, with your dose adjusted based on individual response and tolerance rather than price changes. All medications come from licensed 503A compounding pharmacies verified for quality and sterility. Treatment begins with a medical intake review and personalized protocol designed around your health history and weight loss goals.

Your dose may increase over time as your body adapts, but PlexusDx maintains flat monthly pricing across all commitment tiers—meaning you only pay for the medication itself, not the dose level. HSA and FSA accounts are accepted, providing additional savings for eligible patients. If you choose to add the Precision Peptide Genetic Test after your first month ($99), you'll gain insights into 14 metabolic pathways and 150+ personalized peptide responses to optimize your therapy.

How Your Genetics Influence GLP-1 Response

Not everyone responds to GLP-1 medications the same way. Genetic variants — including GIPR rs1800437, GLP1R rs6923761, FTO rs9939609, and MC4R rs17782313 — influence how your body processes these medications, how much weight you lose, and how you tolerate side effects. PlexusDx maps 14 pathways, 49 peptides, and 150+ genetic insights to match each patient to the right medication, dose, and lifestyle protocol for their biology. The PlexusDx Precision Peptide Genetic Test ($99 add-on after your first month of treatment) gives your provider precise insight into your peptide genetic predispositions before the first prescription is written.

Access Personalized GLP-1 Care Through PlexusDx

PlexusDx offers six prescription GLP-1 protocols to all 50 states — no membership, no insurance required, async intake or live consult. The Semaglutide Injection starts at $149/mo. Medications are dispensed from licensed 503A compounding pharmacies following strict quality and safety standards. Add a Precision Peptide Genetic Test for $99 to personalize your protocol from day one.

Frequently Asked Questions

Can I take semaglutide if I don't have diabetes?

Yes. Semaglutide is FDA-approved for weight management in people with excess weight or obesity, independent of diabetes status. PlexusDx serves patients seeking weight loss therapy without requiring a diabetes diagnosis.

How quickly will I lose weight on semaglutide?

Most patients experience noticeable appetite reduction within the first 2-4 weeks. Measurable weight loss typically becomes apparent after 4-8 weeks as your body adapts to lower food intake. Clinical trials showed an average loss of 15% of body weight over 68 weeks, though individual results vary based on adherence, diet quality, and genetic factors.

What's included in the $149/month price at PlexusDx?

The $149 per month covers compounded semaglutide injection from a licensed 503A pharmacy, delivered to your home. This flat price applies regardless of your dose level—your dose can increase without additional cost. The price does not include the optional Precision Peptide Genetic Test ($99 add-on after month one) or any other services.

Are there serious side effects from semaglutide?

Most side effects are mild and temporary, including nausea, constipation, or occasional stomach discomfort that often improves within 1-2 weeks. Rare but serious risks include pancreatitis, gallbladder issues, or severe allergic reactions. Your PlexusDx provider monitors your progress and adjusts your treatment if side effects become problematic.

How does the Precision Peptide Genetic Test help with semaglutide?

The Precision Peptide Genetic Test examines variants in your GLP1R, GIPR, FTO, and MC4R genes to predict how your body will respond to semaglutide and other peptide therapies. Results map 14 metabolic pathways and 150+ personalized insights, helping PlexusDx refine your dose and protocol for optimal results.

Related Reading

Pricing and availability current as of June 2026. Compounded GLP-1 medications are not FDA-approved drug products; they are prepared by licensed compounding pharmacies under federal compounding regulations. Compounded semaglutide and tirzepatide are not the same as Wegovy, Ozempic, Zepbound, or Mounjaro. This article is for informational purposes only and does not constitute medical advice. Consult a licensed healthcare provider before starting, stopping, or changing any medication.

Return to the PlexusDx Education Hub for more evidence-based resources on GLP-1 therapy, metabolic health, and personalized weight management.

Medical and Editorial Standards

Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.

Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance.

Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.

Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.

Real prescribers. Published prices. No surprises.

Licensed providers in all 50 states. Online intake. No insurance, no membership required.

Start My Intake

~60 seconds · $0 charged until your provider approves